Cargando…
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting
We evaluated the efficacy of using standard radiologic and histologic criteria to guide the follow-up of patients with lobular carcinoma in situ (LCIS), lobular neoplasia (LN), or atypical lobular hyperplasia (ALH). Patients with high-risk benign lesions diagnosed on biopsy were presented and review...
Autores principales: | Middleton, Lavinia P, Sneige, Nour, Coyne, Robin, Shen, Yu, Dong, Wenli, Dempsey, Peter, Bevers, Therese B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101740/ https://www.ncbi.nlm.nih.gov/pubmed/24639339 http://dx.doi.org/10.1002/cam4.223 |
Ejemplares similares
-
The diagnosis and management of pre-invasive breast disease: Pathology of atypical lobular hyperplasia and lobular carcinoma in situ
por: Simpson, Peter T, et al.
Publicado: (2003) -
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010) -
Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021) -
Biology and management of lobular endocervical glandular hyperplasia
por: Miyamoto, Tsutomu, et al.
Publicado: (2022) -
Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)